Home > Insider Trading > Filing (0001209191-22-018866)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1797768	Kinnate Biopharma Inc.	KNTE	Pharmaceutical Preparations (2834)	824566526

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1825148	Thomas Richard Williams	103 Montgomery Street, Suite 150 The Presidio Of San Francisco San Francisco CA 94129	Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-03-11	15,000	$8.64	17,333	No	4	P	Direct
Common Stock	Acquisiton	2022-03-14	25,000	$8.37	42,333	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Footnotes

The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.42 to $8.77, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.
Includes 1,769 shares acquired under the Issuers Employee Stock Purchase Plan (the "Plan") in May 2021 and 564 shares acquired under the Plan in November 2021.
The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.25 to $8.50, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.